2014 Q1 Form 10-Q Financial Statement

#000137371514000084 Filed on May 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $139.1M $85.94M
YoY Change 61.85% 81.19%
Cost Of Revenue $53.11M $32.31M
YoY Change 64.4% 52.14%
Gross Profit $85.98M $53.63M
YoY Change 60.31% 104.74%
Gross Profit Margin 61.81% 62.41%
Selling, General & Admin $91.05M $50.51M
YoY Change 80.27% 96.26%
% of Gross Profit 105.9% 94.17%
Research & Development $31.11M $16.04M
YoY Change 93.96% 165.41%
% of Gross Profit 36.18% 29.91%
Depreciation & Amortization $7.938M $4.364M
YoY Change 81.9% 113.29%
% of Gross Profit 9.23% 8.14%
Operating Expenses $122.2M $66.54M
YoY Change 83.57% 109.41%
Operating Profit -$36.18M -$12.91M
YoY Change 180.19% 131.33%
Interest Expense -$6.000M $100.0K
YoY Change -6100.0% -80.0%
% of Operating Profit
Other Income/Expense, Net -$5.963M $119.0K
YoY Change -5110.92% -75.81%
Pretax Income -$42.14M -$12.79M
YoY Change 229.4% 151.36%
Income Tax $1.167M $564.0K
% Of Pretax Income
Net Earnings -$43.31M -$13.36M
YoY Change 224.23% 136.84%
Net Earnings / Revenue -31.14% -15.54%
Basic Earnings Per Share -$0.10
Diluted Earnings Per Share -$304.7K -$0.10
COMMON SHARES
Basic Shares Outstanding 143.4M shares 131.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $655.8M $338.9M
YoY Change 93.51% 254.87%
Cash & Equivalents $337.9M $144.8M
Short-Term Investments $317.8M $194.1M
Other Short-Term Assets $64.90M $28.60M
YoY Change 126.92% 91.95%
Inventory
Prepaid Expenses
Receivables $107.9M $79.80M
Other Receivables $0.00 $0.00
Total Short-Term Assets $828.6M $447.2M
YoY Change 85.28% 191.74%
LONG-TERM ASSETS
Property, Plant & Equipment $86.20M $54.28M
YoY Change 58.79% 125.24%
Goodwill $8.689M
YoY Change
Intangibles $5.771M
YoY Change
Long-Term Investments $268.6M
YoY Change
Other Assets $4.766M $2.138M
YoY Change 122.92% -71.87%
Total Long-Term Assets $395.6M $68.72M
YoY Change 475.75% 116.77%
TOTAL ASSETS
Total Short-Term Assets $828.6M $447.2M
Total Long-Term Assets $395.6M $68.72M
Total Assets $1.224B $516.0M
YoY Change 137.28% 178.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.66M $9.770M
YoY Change 131.98% 37.61%
Accrued Expenses $48.62M $40.43M
YoY Change 20.25% 148.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.400M
YoY Change
Total Short-Term Liabilities $365.5M $229.1M
YoY Change 59.53% 72.01%
LONG-TERM LIABILITIES
Long-Term Debt $421.8M $0.00
YoY Change
Other Long-Term Liabilities $18.92M $7.059M
YoY Change 168.08% -70.22%
Total Long-Term Liabilities $18.92M $7.059M
YoY Change 168.08% -70.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $365.5M $229.1M
Total Long-Term Liabilities $18.92M $7.059M
Total Liabilities $820.5M $252.0M
YoY Change 225.57% 60.63%
SHAREHOLDERS EQUITY
Retained Earnings -$222.5M -$118.8M
YoY Change 87.22%
Common Stock $626.5M $383.9M
YoY Change 63.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $403.7M $263.9M
YoY Change
Total Liabilities & Shareholders Equity $1.224B $516.0M
YoY Change 137.28% 178.89%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income -$43.31M -$13.36M
YoY Change 224.23% 136.84%
Depreciation, Depletion And Amortization $7.938M $4.364M
YoY Change 81.9% 113.29%
Cash From Operating Activities $24.22M $15.02M
YoY Change 61.2% -6.57%
INVESTING ACTIVITIES
Capital Expenditures $10.97M $10.42M
YoY Change 5.31% 21.7%
Acquisitions $0.00
YoY Change
Other Investing Activities -$64.70M -$600.0K
YoY Change 10683.33% -96.08%
Cash From Investing Activities -$75.68M -$11.01M
YoY Change 587.34% -53.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $22.21M $21.47M
YoY Change 3.47%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $23.15M $22.62M
YoY Change 2.36% 13.52%
NET CHANGE
Cash From Operating Activities $24.22M $15.02M
Cash From Investing Activities -$75.68M -$11.01M
Cash From Financing Activities $23.15M $22.62M
Net Change In Cash -$28.31M $26.63M
YoY Change -206.3% 119.89%
FREE CASH FLOW
Cash From Operating Activities $24.22M $15.02M
Capital Expenditures $10.97M $10.42M
Free Cash Flow $13.25M $4.608M
YoY Change 187.52% -38.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
22664000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7405000 USD
CY2014Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1814000 USD
CY2013Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1095000 USD
CY2014Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
11910000 USD
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
16610000 USD
CY2014Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
48619000 USD
CY2013Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
68130000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68130000 USD
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
48619000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
38107000 USD
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43589000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-242000 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-217000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-234000 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-59000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-476000 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-276000 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
626382000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
573791000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1100000 USD
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1300000 USD
CY2014Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6701000 USD
CY2013Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
5366000 USD
CY2014Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
11149000 USD
CY2014Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
380000 USD
CY2014Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7081000 USD
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23000 USD
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
440000 USD
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
44514864 shares
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34338456 shares
CY2013Q4 us-gaap Assets
Assets
1168476000 USD
CY2014Q1 us-gaap Assets
Assets
1224261000 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
828625000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
797749000 USD
CY2014Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
586477000 USD
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
523607000 USD
CY2014Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
586694000 USD
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
523849000 USD
CY2013 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses
381000 USD
CY2014Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses
409000 USD
CY2014Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
356872000 USD
CY2013Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
375109000 USD
CY2013Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
268251000 USD
CY2014Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
317842000 USD
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
317842000 USD
CY2014Q1 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
192000 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
139000 USD
CY2014Q1 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
409000 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
381000 USD
CY2013Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
255356000 USD
CY2014Q1 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
268635000 USD
CY2014Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7800000 shares
CY2013Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6157000 USD
CY2014Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
11088000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
366303000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
337920000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118989000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
144782000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-28383000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
25793000 USD
CY2013Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
107.46
CY2014Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
52888899 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
143433099 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
140000 USD
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
143000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43111000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14478000 USD
CY2014Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments potentially exposing us to credit risk consist primarily of cash equivalents, investments and accounts receivable. We maintain cash, cash equivalents and investments at financial institutions that management believes to have good credit ratings and represent minimal risk of loss of principal. We invest in securities issued by financial-sector firms with a minimum rating of A by Standard &amp; Poor's and A2 by Moody's and securities issued by non-financial sector firms with a minimum rating of BBB by Standard &amp; Poor's and Baa1 by Moody's.</font><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit risk arising from accounts receivable is mitigated due to our large number of customers and their dispersion across various industries and geographies. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> customers that represented more than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> of our accounts receivable balance. During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> customers that individually exceeded </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> of our revenues.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We review the composition of the accounts receivable balance, historical write-off experience and the potential risk of loss associated with delinquent accounts to determine if an allowance for doubtful accounts is necessary. Individual accounts receivable are written off when we become aware of a specific customer&#8217;s inability to meet its financial obligation and all collection efforts are exhausted. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, the allowance for doubtful accounts was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;">, res</font></div></div>
CY2014Q1 us-gaap Convertible Debt
ConvertibleDebt
421840000 USD
CY2013Q4 us-gaap Convertible Debt
ConvertibleDebt
414777000 USD
CY2014Q1 us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
31189000 USD
CY2013Q1 us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
18312000 USD
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
32308000 USD
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
53114000 USD
CY2013Q1 us-gaap Cost Of Services
CostOfServices
13996000 USD
CY2014Q1 us-gaap Cost Of Services
CostOfServices
21925000 USD
CY2013Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
73.88
CY2014Q1 us-gaap Debt Instrument Convertible Conversion Ratio1
DebtInstrumentConvertibleConversionRatio1
13.54
CY2014Q1 us-gaap Debt Instrument Convertible Earliest Date1
DebtInstrumentConvertibleEarliestDate1
2014-03-31
CY2014Q1 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
7800000 shares
CY2014Q1 us-gaap Debt Instrument Convertible Remaining Discount Amortization Period1
DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
P55M
CY2014Q1 us-gaap Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
July 1, 2018
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
575000000 USD
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
575000000 USD
CY2014Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
575000000 USD
CY2014Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.065
CY2013Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0
CY2014Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2018-11-01
CY2014Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
153160000 USD
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
160223000 USD
CY2013Q4 us-gaap Deferred Costs
DeferredCosts
21318000 USD
CY2014Q1 us-gaap Deferred Costs
DeferredCosts
21575000 USD
CY2013Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
31123000 USD
CY2014Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
32887000 USD
CY2013Q4 us-gaap Deferred Revenue And Credits
DeferredRevenueAndCredits
14169000 USD
CY2014Q1 us-gaap Deferred Revenue And Credits
DeferredRevenueAndCredits
14249000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
252553000 USD
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
294223000 USD
CY2013Q1 us-gaap Depreciation
Depreciation
4328693 USD
CY2014Q1 us-gaap Depreciation
Depreciation
7488873 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4364000 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7938000 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-840000 USD
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-71000 USD
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.04
CY2014Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.03
CY2014Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16311000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22322000 USD
CY2014Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M23D
CY2014Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
70600000 USD
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
940000 USD
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1851000 USD
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1851000 USD
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
940000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
985000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1425000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6781000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7196000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5796000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5771000 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12279000 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21631000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
8724000 USD
CY2014Q1 us-gaap Goodwill
Goodwill
8689000 USD
CY2014Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2014Q1 us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-35000 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
85976000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
53631000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-42144000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-12794000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1167000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
564000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1471000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12075000 USD
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-8959000 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-21328000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
13232000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
9269000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
42172000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
25729000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8910000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3688000 USD
CY2014Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
27000 USD
CY2013Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2938000 USD
CY2014Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
55000 USD
CY2013Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5771000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5796000 USD
CY2014Q1 us-gaap Liabilities
Liabilities
820519000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
774217000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1168476000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1224261000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
328088000 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
365506000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22621000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23154000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11011000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-75683000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15023000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24217000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-43311000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-13358000 USD
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13358000 USD
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-43311000 USD
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13358000 USD
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-43311000 USD
CY2013Q4 us-gaap Noncurrent Assets
NoncurrentAssets
75560000 USD
CY2014Q1 us-gaap Noncurrent Assets
NoncurrentAssets
86200000 USD
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
119000 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5963000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
66544000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
122157000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-36181000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-12913000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3973000 USD
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4766000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
175000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-1166000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
200000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1120000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-33000 USD
CY2013Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
11926000 USD
CY2014Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
10043000 USD
CY2014Q1 us-gaap Other Liabilities
OtherLiabilities
6153000 USD
CY2013Q4 us-gaap Other Liabilities
OtherLiabilities
13085000 USD
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18924000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17183000 USD
CY2014Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
507000 USD
CY2013Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
581000 USD
CY2014Q1 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0 USD
CY2014Q1 us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
135800000 USD
CY2013Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
55946000 USD
CY2014Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
134856000 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10415000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10968000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
84500000 USD
CY2014Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2013Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-698000 USD
CY2013Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
55350000 USD
CY2014Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
44668000 USD
CY2013Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32044000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23733000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22214000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
21468000 USD
CY2014Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
25528000 USD
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
129789000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
113667000 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86200000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75560000 USD
CY2014Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
107932000 USD
CY2013Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
108339000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31110000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16039000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-179196000 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-222507000 USD
CY2013Q1 us-gaap Revenues
Revenues
85939000 USD
CY2014Q1 us-gaap Revenues
Revenues
139090000 USD
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
139090000 USD
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
85939000 USD
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
14381000 USD
CY2014Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
21715000 USD
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
142060025 shares
CY2013Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
38226000 USD
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
69416000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
12046000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
29229000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
8738620 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.85
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
145896000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
221480 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
31.72
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1047622000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
20931056 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
23399374 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.93
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.07
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1028819000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
20506488 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.75
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.47
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
65.37
CY2013Q4 us-gaap Share Price
SharePrice
56.01
CY2014Q1 us-gaap Share Price
SharePrice
59.92
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
481206000 USD
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y0M7D
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M9D
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y6M5D
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
8100000 USD
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2454203 shares
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
403742000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
394259000 USD
CY2014Q1 us-gaap Subscription Revenue
SubscriptionRevenue
117375000 USD
CY2013Q1 us-gaap Subscription Revenue
SubscriptionRevenue
71558000 USD
CY2014Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
4202000 USD
CY2013Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4187000 USD
CY2014Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
25000 USD
CY2013Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
13000 USD
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </font></div></div>
CY2013Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
600000 USD
CY2014Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
700000 USD
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
129782029 shares
CY2014Q1 now Available For Sale Securities In Gross Unrealized Loss Position Maturities Term Maximum
AvailableForSaleSecuritiesInGrossUnrealizedLossPositionMaturitiesTermMaximum
P12M
CY2014Q1 now Available For Sale Securities Maturities Term Maximum
AvailableForSaleSecuritiesMaturitiesTermMaximum
P24M
CY2014Q1 now Availableforsale Securities Debt Maturities Year Two Through Three Fair Value
AvailableforsaleSecuritiesDebtMaturitiesYearTwoThroughThreeFairValue
268635000 USD
CY2014Q1 now Conversion Of Notes Base Conversion Price
ConversionOfNotesBaseConversionPrice
1000 USD
CY2014Q1 now Maximum Percentof Target Awardof Stock Plan
MaximumPercentofTargetAwardofStockPlan
2
CY2014Q1 now Minimum Percentof Target Awardof Stock Plan
MinimumPercentofTargetAwardofStockPlan
0
CY2014Q1 now Note Hedged Shares Of Common Stock Covered
NoteHedgedSharesOfCommonStockCovered
7800000 shares
CY2014Q1 now Number Of Customer Accounted On Accounts Receivable Balance
NumberOfCustomerAccountedOnAccountsReceivableBalance
0 Customer
CY2013Q4 now Number Of Customer Accounted On Accounts Receivable Balance
NumberOfCustomerAccountedOnAccountsReceivableBalance
0 Customer
CY2014Q1 now Number Of Shares Cancelled
NumberOfSharesCancelled
235595 shares
CY2014Q1 now Percentage Of Purchase Price Of Notes Which Should Be Paid Upon Fundamental Change
PercentageOfPurchasePriceOfNotesWhichShouldBePaidUponFundamentalChange
1.00
CY2014Q1 now Percentage Of Revenue
PercentageOfRevenue
0.1
CY2014Q1 now Percentage Of Revenues Customers Exceeded Individually
PercentageOfRevenuesCustomersExceededIndividually
0.1
CY2014Q1 now Percentageof U.S.Revenuesin North America
PercentageofU.S.RevenuesinNorthAmerica
0.94
CY2013Q1 now Percentageof U.S.Revenuesin North America
PercentageofU.S.RevenuesinNorthAmerica
0.94
CY2014Q1 now Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Otherthan Options Estimated Percentageof Performance Goal Target Earned
SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsEstimatedPercentageofPerformanceGoalTargetEarned
1.145
CY2014Q1 now Weighted Average Exercise Price Cancelled
WeightedAverageExercisePriceCancelled
22.21
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001373715
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
143433099 shares
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
SERVICENOW, INC.
CY2014Q1 dei Trading Symbol
TradingSymbol
NOW

Files In Submission

Name View Source Status
0001373715-14-000084-index-headers.html Edgar Link pending
0001373715-14-000084-index.html Edgar Link pending
0001373715-14-000084.txt Edgar Link pending
0001373715-14-000084-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
now-20140331.xml Edgar Link completed
now-20140331.xsd Edgar Link pending
now-20140331_cal.xml Edgar Link unprocessable
now-20140331_def.xml Edgar Link unprocessable
now-20140331_lab.xml Edgar Link unprocessable
now-20140331_pre.xml Edgar Link unprocessable
now-2014331x10q.htm Edgar Link pending
now-2014331xex311.htm Edgar Link pending
now-2014331xex312.htm Edgar Link pending
now-2014331xex321.htm Edgar Link pending
now-2014331xex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
servicenowrlogostandarda01.jpg Edgar Link pending
Show.js Edgar Link pending